These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 4721664)
1. [Recent concepts of arteriosclerosis, studied in correlation with the classification of hyperlipoproteinemia and the indicated laboratory methods]. Malcolm J; Lockwood P; Hunt P; Thomas B Brux Med; 1973 Mar; 53(3):179-87. PubMed ID: 4721664 [No Abstract] [Full Text] [Related]
2. [Blood lipid disorder according to modern laboratory and clinical concepts (hyperlipoproteinemia)]. Popescu PN; Idu SM Med Interna (Bucur); 1971 Mar; 23(3):293-302. PubMed ID: 5574926 [No Abstract] [Full Text] [Related]
3. [Recent concepts on arteriosclerosis seen in special correlation to lipoprotein particles]. Malcolm J; Hunt P Brux Med; 1971 Jan; 51(1):43-56. PubMed ID: 5549727 [No Abstract] [Full Text] [Related]
4. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atheroslcerosis. Part I: Principles of classification and methods of dyslipoproteinemia determination. Choluj B; Votruba T; Kormúth E Acta Univ Carol Med (Praha); 1991; 37(3-4):91-105. PubMed ID: 1845469 [TBL] [Abstract][Full Text] [Related]
5. [Diabetes and hyperlipoproteinemia in coronary atherosclerosis]. Zorrilla E; Hernández A; Magos C; Serrano PA Acta Diabetol Lat; 1971; 8(4):629-37. PubMed ID: 5127308 [No Abstract] [Full Text] [Related]
6. Plasmalipoproteins and atherosclerosis. Schettler G Arch Inst Cardiol Mex; 1975; 45(3):335-43. PubMed ID: 168820 [TBL] [Abstract][Full Text] [Related]
7. [Primary hyperlipoproteinemia of type V]. Kucerová L; Voslárová Z; Papezová R Vnitr Lek; 1974 Sep; 20(9):869-76. PubMed ID: 4410504 [No Abstract] [Full Text] [Related]
8. [Advances in pharmacotherapy of arteriosclerosis]. Balewska K; Witanowska A Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):103-7. PubMed ID: 2216947 [No Abstract] [Full Text] [Related]
9. The influence of drugs affecting lipids on atherosclerosis. Ditschuneit H Horm Metab Res; 1974; Suppl 4():191-4. PubMed ID: 4421312 [No Abstract] [Full Text] [Related]
10. [Classification of hyperlipoproteinemias and the problem of "atherogenicity"]. Fasoli A G Ital Cardiol; 1971; 1(4):287-90. PubMed ID: 5126211 [No Abstract] [Full Text] [Related]
12. [Effect of a new lipid-reducing preparation in case of hyperlipoproteinemia]. Knüchel F Med Welt; 1974 Oct; 25(43):1766-9. PubMed ID: 4419179 [No Abstract] [Full Text] [Related]
13. [Current position in the treatment of arteriosclerosis]. Emmrich R Z Alternsforsch; 1974; 28(1):31-8. PubMed ID: 4409098 [No Abstract] [Full Text] [Related]
14. [Therapeutic effect of clofibrate in a patient with primary hyperlipoproteinemia type 3]. Plamieniak L Wiad Lek; 1974 May; 27(9):811-4. PubMed ID: 4849978 [No Abstract] [Full Text] [Related]
15. [Hyperlipoproteinemia type 3. Report on 5 cases]. Weber K; Braun-Falco O; Wolfram G Hautarzt; 1973 May; 24(5):179-85. PubMed ID: 4753368 [No Abstract] [Full Text] [Related]
16. [Significance of the lipidogram (Lees-Hatch technic) associated with the determination of serum lipid fractions for the detection and classification of hyperlipoproteinemias. (Apropos of 100 arteriosclerosis patients)]. Loeper J; Tricot R; Rouffy J Presse Med (1893); 1969 Jan; 77(5):171-2. PubMed ID: 5771795 [No Abstract] [Full Text] [Related]
19. [Treatment of hyperlipoproteinemia in relation to recent classifications]. Cloarec M Minerva Med; 1971 Sep; 62(72):3452-5. PubMed ID: 5097215 [No Abstract] [Full Text] [Related]
20. Diet and drug therapy for hyperlipoproteinemia. Maha GE Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828 [No Abstract] [Full Text] [Related] [Next] [New Search]